ESR1 and breast carcinoma: Therefore, we investigated whether C4PY elicits an inhibitory action through GPER in CAFs derived from breast cancer patients, because these cells express GPER and lack ER (De Francesco et al., 2014; Madeo and Maggiolini, 2010; Pupo et al., 2013).